ANDA 208480, held by Macleods Pharms. Atorvastatin Calcium.
As of Nov 16, 2026, ANDA 208480 (Atorvastatin Calcium), held by Macleods Pharms, was first approved by FDA on Jun 3, 2024, with 0 approved supplements and 0 published complete response letters.
Atorvastatin calcium tablets is indicated:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 3, 2024 | Original application | Approved | None posted |
| Atorvastatin CalciumEQ 10MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 20MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 40MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 80MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters